Egg-freezing has risen in lockdown, but it’s not the cure-all it’s cracked up to be
By Katie Strick and Lucy Holden,
Evening Standard
| 11. 10. 2020
Alice Mann wishes she’d known the odds from the start. The marketing consultant was 36, single and heartbroken after the end of a two-year relationship when she read a magazine article about freezing her eggs, a process which allows women to preserve them to use in IVF at a later date. She knew she wanted children, so spending £14,000 on the procedure felt like a worthwhile (albeit expensive) insurance policy, a way of buying some “breathing space” in the hope that she’d meet someone new.
It came as a shock, then, still single at 40 and mid-way through an attempt to fertilise her frozen eggs with donor sperm, when she received a call from the clinic. Of the seven eggs they’d defrosted, only two fertilised and both were abnormal, so there were no embryos left.
“I was utterly floored by the news and felt angry; resentful at the universe,” says Mann, now 43 and undergoing IVF with a new partner. “Tears welled in my eyes because I thought the worst-case scenario would be one slightly crappy...
Related Articles
By Diaa Hadid and Shweta Desai, NPR | 01.29.2026
MUMBRA, India — The afternoon sun shines on the woman in a commuter-town café, highlighting her almond-shaped eyes and pale skin, a look often sought after by couples who need an egg to have a baby.
"I have good eggs,"...
By George Janes, BioNews | 01.12.2026
A heart attack patient has become the first person to be treated in a clinical trial of an experimental gene therapy, which aims to strengthen blood vessels after coronary bypass surgery.
Coronary artery bypass surgery is performed to treat...
By Staff, ScienceDaily | 01.05.2026
Scientists at UNSW Sydney have developed a new form of CRISPR technology that could make gene therapy safer while also resolving a decades-long debate about how genes are switched off. The research shows that small chemical markers attached to DNA
...
Following a long-standing CGS tradition, we present a selection of our favorite Biopolitical Times posts of the past year.
In 2025, we published up to four posts every month, written by 12 authors (staff, consultants and allies), some in collaboration and one simply credited to CGS.
These titles are presented in chronological order, except for three In Memoriam notices, which follow. Many more posts that are worth your time can be found in the archive. Scroll down and “VIEW...